Singapore's Covid-19 neutralising antibody test kit first to get US FDA approval; eight cases on Mon (Nov 9)


cPass does not require highly specialised equipment or training to use, and returns results in just an hour. - The Straits Times/Asian News Network

SINGAPORE, Nov 9 (The Straits Times/ANN): A kit that detects whether someone has antibodies which neutralise the coronavirus, invented by local researchers, has become the first of its kind to receive authorisation from the United States' Food and Drug Administration (FDA).

On Friday (Nov 6), the FDA said on its website that it had given emergency use authorisation for the kit, known as cPass.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

US-backed higher education project launches to upgrade Lao universities
Singapore Civil Defence Force officer gets six months’ jail over death of national serviceman firefighter
Maria Cordero speaks out on Thailand kidnapping fears, shares her own terrifying gunpoint incident in Indonesia alongside Simon Yam
Thailand eases visa rules for professionals, wealthy foreigners
Trump's Greenland bid stirs debate in China about what to do with Taiwan
Jail for vice syndicate's Singaporean mastermind who lived on sex workers’ earnings totalling over S$264,000
Well rounded education: Young Cambodian monks learning English, computer skills
Murder of Malaysian student: Death penalty upheld in Taiwan court retrial
Actress Yvonne Lim moves back to Singapore after 10 years in Taiwan
Vietnam vows to facilitate Russian businesses, says PM Chinh

Others Also Read